Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-014891
Filing Date
2015-08-05
Accepted
2015-08-05 16:52:54
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q erb20150630_10q.htm 10-Q 1018542
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12594
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 12705
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5387
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5773
  Complete submission text file 0001437749-15-014891.txt   3861763

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS erb-20150630.xml EX-101.INS 672235
7 EXHIBIT 101.SCH erb-20150630.xsd EX-101.SCH 36665
8 EXHIBIT 101.CAL erb-20150630_cal.xml EX-101.CAL 37723
9 EXHIBIT 101.DEF erb-20150630_def.xml EX-101.DEF 183627
10 EXHIBIT 101.LAB erb-20150630_lab.xml EX-101.LAB 246497
11 EXHIBIT 101.PRE erb-20150630_pre.xml EX-101.PRE 183773
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127 305-324-2300
ERBA Diagnostics, Inc. (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14798 | Film No.: 151029636
SIC: 2834 Pharmaceutical Preparations